Iqvia Holdings Inc Stock price Nyse
Equities
US74876Y1010
Biotechnology & Medical Research
Financials (USD)
Sales 2024 * | 15.54B | Sales 2025 * | 16.67B | Capitalization | 46.21B |
---|---|---|---|---|---|
Net income 2024 * | 1.33B | Net income 2025 * | 1.58B | EV / Sales 2024 * | 3.75 x |
Net Debt 2024 * | 12.07B | Net Debt 2025 * | 11.65B | EV / Sales 2025 * | 3.47 x |
P/E ratio 2024 * |
34.7
x | P/E ratio 2025 * |
29.1
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 70.18% |
Latest transcript on Iqvia Holdings Inc
Managers | Title | Age | Since |
---|---|---|---|
Ari Bousbib
CEO | Chief Executive Officer | 62 | 16-10-02 |
Ronald Bruehlman
DFI | Director of Finance/CFO | 63 | 20-07-31 |
James Berkshire
COO | Chief Operating Officer | 51 | 17-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Danhakl
BRD | Director/Board Member | 67 | 16-10-02 |
Colleen Goggins
BRD | Director/Board Member | 68 | 17-07-26 |
Ari Bousbib
CEO | Chief Executive Officer | 62 | 16-10-02 |
1st Jan change | Capi. | |
---|---|---|
+34.86% | 40.04B | |
+4.84% | 39.92B | |
-9.43% | 28.33B | |
+17.47% | 27.43B | |
-22.99% | 18.57B | |
+10.88% | 13.46B | |
+27.53% | 12.02B | |
-6.84% | 11.3B | |
+6.40% | 11.01B |